Suppressive effect of leflunomide metabolite (A77 1726) on metalloproteinase production in IL-1β stimulated rheumatoid synovial fibroblasts

Leflunomide, an isoxazol derivative structurally unrelated to other immunomodulatory drugs, has proven to be efficacious in the treatment of rheumatoid arthritis (RA). This study was conducted to elucidate the mechanism by which leflunomide mediated antirheumatic effects. We investigated the effects...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: MIGITA, K, MIYASHITA, T, ISHIBASHI, H, MAEDA, Y, NAKAMURA, M, YATSUHASHI, H, IDA, H, KAWAKAMI, A, AOYAGI, T, KAWABE, Y, EGUCHI, K
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Blackwell Science Inc 2004
Aiheet:
Clinical Studies
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC1809130/
https://ncbi.nlm.nih.gov/pubmed/15320915
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2249.2004.02555.x
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia